Advertisement
Singapore markets closed

  • Straits Times Index

    3,287.75
    -5.38 (-0.16%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • Dow

    38,460.92
    -42.77 (-0.11%)
     

  • Nasdaq

    15,712.75
    +16.11 (+0.10%)
     

  • Bitcoin USD

    63,857.12
    -2,686.38 (-4.04%)
     

  • CMC Crypto 200

    1,354.31
    -28.26 (-2.05%)
     

  • FTSE 100

    8,093.78
    +53.40 (+0.66%)
     

  • Gold

    2,341.20
    +2.80 (+0.12%)
     

  • Crude Oil

    83.00
    +0.19 (+0.23%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • Nikkei

    37,628.48
    -831.60 (-2.16%)
     

  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     

  • FTSE Bursa Malaysia

    1,569.25
    -2.23 (-0.14%)
     

  • Jakarta Composite Index

    7,155.29
    -19.24 (-0.27%)
     

  • PSE Index

    6,574.88
    +2.13 (+0.03%)
     

QLT Inc. (QLTI) Soars: Stock Adds 7.9% in Session

Zacks Equity Research

QLT Inc. (QLTI) was a big mover last session, as its shares rose nearly 8% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This reverses the downtrend for the company, as the stock is now up nearly 5% in the past one-month timeframe.

In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep an eye on the stock going forward.

QLT currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Other better-ranked stocks in med-drugs industry include Enanta Pharmaceuticals, Inc. (ENTA), Endo International plc (ENDP) and BioCryst Pharmaceuticals, Inc. (BCRX). All three carry a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


ENDO INTERNATIONAL PLC ORD (ENDP): Free Stock Analysis Report

ENANTA PHARMACEUTICALS INC (ENTA): Free Stock Analysis Report

BIOCRYST PHARMACEUTICALS INC (BCRX): Free Stock Analysis Report

(QLTI): Free Stock Analysis Report


Zacks Investment Research